Pre-admission antibiotics for suspected cases of meningococcal disease

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2008, Pages

  Sudarsanam, Thambu ^a   Rupali, P ^b   Tharyan, P ^b   Abraham, O C ^b   Thomas, K ^b  

^a CHRISTIAN MEDICAL COLLEGE   (India)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN; CHLORAMPHENICOL; CIPROFLOXACIN; LONG ACTING DRUG; MACROLIDE; MINOCYCLINE; NORFLOXACIN; OFLOXACIN; PENICILLIN G; PLACEBO; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULFANILAMIDE; SULFONAMIDE;

ABSENCE OF SIDE EFFECTS; ANTIBIOTIC RESISTANCE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DATA EXTRACTION; DATA SYNTHESIS; DIAGNOSTIC PROCEDURE; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; EPIDEMIC MENINGITIS; HOSPITAL ADMISSION; HUMAN; INFORMATION PROCESSING; INTERVENTION STUDY; MEDICAL RESEARCH; MENINGOCOCCOSIS; MORBIDITY; MORTALITY; QUALITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SINGLE DRUG DOSE; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 44949146218     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005437.pub2     Document Type: Review

References (52)

1. Nathan 2005 {published data only} Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al.Ceftrioxone as effective as long-acting chloramphenicol in short-course treatment of meningiococcal meningitis during epidemics:a randomised non-inferiority study. Lancet 2005;366:308- 13.
2. Barquet 1997 Barquet N, Domingo P, Cayla JA, Gonzalez J, Rodrigo C, Fernandez-Viladrich P, et al.Prognostic factors in meningococcal disease: Development of a bedside predictive model and scoring system. Journal of the American Medical Association 1997;278(6):491-6.
3. Barquet 1999 *Barquet N, Domingo P, Cayla JA, Gonzalez J, Rodrigo C, Fernandez-Viladrich P, et al.Meningococcal disease in a large urban population (Barcelona, 1987 - 1992): Predictors of dismal prognosis. Archives of Internal Medicine 1999;159(19):2329-40.
4. Barson 1985 Barson WJ, Miller MA, Brady MT, Powell DA. Prospective comparative trial of ceftriaxone vs. conventional therapy for treatment of bacterial meningitis in children. Pediatric Infectious Disease 1985;4(4):362-8.
5. Bohr 1983 Bohr V, Rasmussen N, Hansen B, Kjersem H, Jessen O, Johnsen N, et al.875 cases of bacterial meningitis: diagnostic procedures and the impact of preadmission antibiotic therapy. Part III of a three-part series. Journal of Infection 1983;7(3):93-202.
6. BSSI 1995 The Research Committee of the BSSI. Bacterial meningitis: Causes for concern. Journal of infection 1995;30(2): 89-94.
7. Cartwright 1992 Cartwright K, Reilly S, White D, Stuart J. Early treatment with parenteral penicillin in meningococcal disease. British Medical Journal 1992;305(6846):143-7.
8. Congeni 1984 Congeni BL. Comparison of ceftriaxone and traditional therapy of bacterial meningitis. Antimicrobial Agents & Chemotherapy 1984;25(1):40-4.
9. del Rio 1983 del Rio MA, Chrane D, Shelton S, McCracken GH Jr, Nelson JD. Ceftriaxone versus ampicillin and chloramphenicol for treatment of bacterial meningitis in children. Lancet 1983;321(8336):1241-4.
10. Gedde-Dahl 1990 Gedde-Dahl TW, Hoiby EA, Brandtzaeg P, Eskerud JR, Bovre K. Some arguments on early hospital admission and treatment of suspected meningococcal disease cases. NIPH Annals 1990;13(2):45-60.
11. Girgis 1989 Girgis NI, Farid Z, Mikhail IA, Farrag I, Sultan Y, Kilpatrick ME. Dexamethasone treatment for bacterial meningitis in children and adults. Pediatric Infectious Disease Journal 1989;8(12):848-51.
12. Gunn 1996 Gunn A, Hollyoak V. Meningitis: public health issues. Nursing Times 1996;92(6):27-9.
13. Harnden 2006 Harnden A, Ninis N, Thompson M, Perera R, Levin M, Mant D, et al.Parenteral penicillin for children with meningococcal disease before hospital admission: case-control study. British Medical Journal 2006;332(7553):1295-8.
14. Jolly 2001 Jolly K, Stewart G. Epidemiology and diagnosis of meningitis: results of a five-year prospective, population-based study. Communicable Disease and Public Health 2001;4(2):124-9.
15. Kavaliotis 1989 Kavaliotis J, Manios SG, Kansouzidou A, Danielidis V. Treatment of childhood bacterial meningitis with ceftriaxone once daily: open, prospective, randomized, comparative study of short-course versus standard-length therapy. Chemotherapy 1989;35(4):296-303.
16. Martin 1990 Martin E, Hohl P, Guggi T, Kayser FH, Fernex M. Short course single daily ceftriaxone monotherapy for acute bacterial meningitis in children: results of a Swiss multicenter study. Part I: Clinical results. Infection 1990;18(2):70-7.
17. Newcombe 1997 Newcombe J, Dyer S, Blackman L, Cartwright K, Palmer WH, McFadden J. PCR-single-stranded confirmational polymorphism analysis for non-culture-based subtyping of meningococcal strains in clinical specimens. Journal of Clinical Microbiology 1997;35(7):1809-12.
18. Noorgard 2002 Noorgard B, Soorensen HT, Jensen ES, Faber T, Schoonheyder HC, et al.Pre-hospital parenteral antibiotic treatment of meningococcal disease and case fatality: A Danish population-based cohort study. Journal of Infection 2002;45(3):144-51.
19. Pecoul 1991 Pecoul B, Varaine F, Keita M, Soga G, Djibo A, Soula G, et al.Long-acting chloramphenicol versus intravenous ampicillin for treatment of bacterial meningitis. Lancet 1991;338(8771):862-6.
20. Quagliarello 2003 Quagliarello V. Short-course penicillin therapy for meningococcal disease: Accumulating evidence and persistent uncertainty. Clinical Infectious Diseases 2003;37(5):663-4. [MEDLINE: 2003369547].
21. Riordan 2001 Riordan FAI. Improving promptness of antibiotic treatment in meningococcal disease. Emergency Medicine Journal 2001;18(3):162-3. [MEDLINE: 2002028693].
22. Rodriguez 1986 Rodriguez WJ, Puig JR, Khan WN, Feris J, Gold BG, Sturla C. Ceftazidime vs. standard therapy for pediatric meningitis: therapeutic, pharmacologic and epidemiologic observations. Pediatric Infectious Disease 1986;5(4):408-15.
23. Roord 2001 Roord JJ, Kaandorp CJ. CBO-guideline 'Bacterial meningitis'. Nederlands Tijdschrift voor Geneeskunde 2001;145(5): 211-4.
24. Roznovsky 2003 Roznovsky L, Krizova P, Struncova V, Dostal V, Plisek S, Kasal E, et al.Administration of antibiotics before admission in patients with meningococcal disease. Central European Journal of Public Health 2003;11(1):14-8.
25. Schaad 1990 Schaad UB, Suter S, Gianella-Borradori A, Pfenninger J, Auckenthaler R, Bernath O, et al.A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children. New England Journal of Medicine 1990;322(3):141-7.
26. Sorensen 1998 Sorensen HT, Nielsen GL, Schonheyder HC, Steffensen FH, Hansen I, Sabroe S, et al.Outcome of pre-hospital antibiotic treatment of meningococcal disease. Journal of Clinical Epidemiology 1998;51(9):717-21. [MEDLINE: 1998321631].
27. Strang 1992 Strang JR, Pugh EJ. Meningococcal infections: reducing the case fatality rate by giving penicillin before admission to hospital. British Medical Journal 1992;305(6846):141-3.
28. Wald 1995 Wald ER, Kaplan SL, Mason EOJ, Sabo D, Ross L, Arditi M, et al.Dexamethasone therapy for children with bacterial meningitis. Pediatrics 1995;95(1):21-31.
29. Wylie 1997 Wylie PAL, Stevens D, Drake III W, Stuart J, Cartwright K. Epidemiology and clinical management of meningococcal disease in west Gloucestershire: Retrospective, population based study. British Medical Journal 1997;315(7111):774-9. [MEDLINE: 1997291389].
30. Leclerc 2001 Leclerc F, Noizet O, Dorkenoo A, Cremer R, Leteurtre S, Sadik A, et al.Treatment of meningococcal purpura fulminans. Archives de Pediatrie 2001;8(Suppl 4):667-88. [MEDLINE: 2001324586].
31. Alderson 2004 Alderson P, Green S, Higgins JPT, editors. Appendix 5b. Cochrane Reviewers' Handbook 4.2.2 [updated December 2003]. In: The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd, 2004.
32. Booy 2001 Booy R, Habibi P, Nadel S, deMunter C, Britto Morrison JA, Levin M, et al.Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery. Archives of Disease in Childhood 2001;85:386-90.
33. Bramley 1999 Bramley JC, Begg NT, Booy R, Buttery J, Finn A, Heath PT, et al.Conjugate vaccines for preventive meningococcal C meningitis and septicemia. Cochrane Database of Systematic Reviews 1999, Issue 4.
34. Deeks 2003 Deeks JJ, Higgins JPT, Altman DG. Analysing and presenting results. In: AldersonP, GreenS, HigginsJ editor(s). Cochrane Reviewers' Handbook 4.2.2 [updated December 2003]. In: The Cochrane Library, Issue 1. Chichester, UK: John Wiley & Sons, Ltd, 2004.
35. Duke 2003 Duke T, Michael A, Mokela D, Wal T, Reeder J. Chloramphenicol or ceftriaxone, or both, as treatment for meningitis in developing countries?. Archives of Disease in Childhood 2003;88(6):536-9.
36. Eickhoff 1965 Eickhoff TC, Finland M. Changing susceptibility of meningococci to antimicrobial agents. New England Journal of Medicine 1965;272:395-8.
37. El Bashir 2003 El Bashir H, Laundy M, Booy R. Diagnosis and treatment of bacterial meningitis. Archives of Disease in Childhood 2003;88:615-20.
38. Ferguson 2002 Ferguson LE, Hormann MD. Neisseria meningitidis: Presentation, treatment and prevention. Journal of Pediatric Health Care 2002;16:119-24.
39. Girgis 1998 Girgis N, Sultan Y, Frenck RW Jr, El-Gendy A, Farid Z, Mateczun A. Azithromycin compared with rifampin for eradication of nasopharyngeal colonization by Neisseria meningitidis. Pediatric Infectious Diseases Journal 1998;17:816-9.
40. Hahné 2006 Hahné SJM, Charlett A, Purcell B, Samuelsson S, Camaroni I, Ehrhard I, et al.Effectiveness of antibiotics given before admission in reducing mortality from meningococcal disease: systematic review. British Medical Journal 2006;332:1299-303.
41. Higgins 2003 Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. British Medical Journal 2003;327:557-60.
42. Kanegaye 2001 Kanegaye JT, Soliemanzadeh P, Bradley JS. Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment. Pediatrics 2001;108:1169-74.
43. Keeley 2006 Keeley D. Parenteral penicillin before admission to hospital for meningitis. British Medical Journal 2006;332:1283-4.
44. MRF 2003 Meningitis Research Foundation. Meningococcal meningitis and septicaemia: guidance notes. Diagnosis and treatment in general practice. www.meningitis.org/uploads/GP%20leaflet%2012.03.pdf (accessed 13 January 2007) 2003.
45. Pecoul 1999 Pecoul B, Chirac P, Trouiller P, Pinel J, Pecoul B, Chirac P, et al.Access to essential drugs in poor countries: a lost battle?. Journal of the American Medical Association 1999;281(4):361-7.
46. Perera 2006 Perera R. Statistics and death frommeningococcal disease in children. British Medical Journal 2006;332(7553):1297- 8.
47. Piaggio 2006 Piaggio G, Elbourne D, Altman DG, Pocock SJ, Evans SJW, for the CONSORT Group. Reporting of Noninferiority and Equivalence Randomized Trials. An Extension of the CONSORT Statement. Journal of the American Medical Association 2006;295:1152-60.
48. Rosenstein 2001 Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM. Meningococcal disease. New England Journal of Medicine 2001;344:1378-88.
49. Schwartz 1989 Schwartz B, Moore PS, Broome CV. Global epidemiology of meningococcal disease. Clinical Microbiology Reviews 1989;2(Suppl):118-24.
50. WHO 1995 WHO Working Group. Control of epidemic meningococcal diseases: WHO Practical guidelines. Lyon, France: Edition Foundation Marcel Merieux, 1995.
51. WHO 2003 World Health Organization. Meningococcal disease. http://www.who.int/mediacentre/factsheets/2003/fs141/en/2003; Vol. May:Fact sheet No 141.
52. WHO 2004 World Health Organization. Meningococcal meningitis. http://www.who.int/csr/disease/meningococcal/en/ (Accessed February 2004) 2004.